Effect of TENS on Patient Outcomes After Laparoscopic Cholecystectomy
NCT ID: NCT05962853
Last Updated: 2025-09-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
140 participants
INTERVENTIONAL
2023-06-15
2024-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
TENS for Anxiety, Pain, and Satisfaction After Laparoscopic Cholecystectomy
NCT07307703
Effective Postoperative Pain Relief After Laparoscopic Cholecystectomy With TENS
NCT04114149
Application of Transcutaneous Electrical Acupoint Stimulation in Laparoscopic Cholecystectomy
NCT05936918
"The Efficiency of Laparoscopic-assisted Transversus Abdominis Plane Block for Post-laparoscopic Cholecystectomy Pain
NCT04641403
Liver Cauterization Increases the Postoperative Pain After Laparoscopic Cholecystectomy
NCT02852408
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The most common complication after laparoscopic cholecystectomy is pain. Pain appears as incisional, visceral and shoulder pain after laparoscopic cholecystectomy.After laparoscopic surgery, increased intra-abdominal pressure, stretching of the peritoneum, inability to take air given carbon dioxide (CO2), shoulder pain due to tension of muscle fibers due to diaphragm irritation, and visceral pain due to the interference of trocars on the abdominal wall as a result of intra-abdominal intervention are seen. After laparoscopic cholecystectomy, the effect of general anesthesia and the proximity of the incision area to the diaphragm may also cause pulmonary complications. Pneumoperiteneum developed by the administration of CO2 gas after laparoscopic cholecystectomy; Diaphragmatic irritation, increased intra-abdominal pressure, stretching of the peritoneum, and consequently the tension in the muscle fibers in the diaphragm can cause pain.
Inability to control pain can lead to many undesirable conditions in the patient, such as reluctance to mobilize, increased oxygen consumption, and delayed wound healing. This situation is also associated with increased hospital stay and financial burdens.In order to provide effective pain control, the combined use of pharmacological and non-pharmacological methods is important.Non-pharmacological methods are easy to learn, safe, have no definite contraindications, and provide pain management with non-drug applications. In a meta-analysis, it was determined that Transcutaneous Electrical Nerve Stimulation (TENS) is an effective, safe non-pharmacological method for symptomatic relief of pain and discomfort and no serious side effects were observed.
Studies have shown that TENS application reduces postoperative pain level and analgesia consumption. In addition, TENS application after laparoscopic cholecystectomy was found to be associated with a decrease in postoperative pain severity and complaints of nausea and vomiting. It is seen that there are not enough resources in the literature regarding the application of TENS after laparoscopic cholecystectomy.
The aim of this study is to evaluate the effect of TENS on patient outcomes after laparoscopic cholecystectomy.
.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
Application of the control group: TENS will not be applied to this group
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental group ( TENS will be applied )
After 30 minutes of TENS application 2 hours after the surgery, TENS will be applied 3 times at 8 hour intervals. Postoperatively at the 2nd hour (just before TENS), at the 3rd hour (1 hour after the onset of TENS), at the 10th hour (just before the TENS), at the 11th hour (1 hour after the start of TENS), at the 18th hour ( Just before TENS) at the 19th Hour (1 hour after the start of TENS). TENS application hours will be arranged according to the patient in order to protect sleep integrity.
Experimental group (Transcutaneous Electrical Nerve Stimulation)
The application will be applied at 8 hour intervals in the first 24 hours after the surgery.
Control Group ( TENS will not be applied )
Application of the control group: TENS will not be applied to this group.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Experimental group (Transcutaneous Electrical Nerve Stimulation)
The application will be applied at 8 hour intervals in the first 24 hours after the surgery.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Without pacemaker and arrhythmia,
* No previous history of chronic pain, alcohol or drug addiction,
* Not using TENS/opioids before surgery,
* Epidural analgesia is not applied in the postoperative period, without cognitive impairment,
* No thoracic incision other than cholecystectomy,
* Having at least 1 drain
* No metastatic disease
* No need for mechanical ventilation
* As a result of the evaluation by the physician, there is no objection to the application of TENS,
* Who agree to participate in the study,
* No postoperative complications
* Patients with American Society of Anesthesiology (ASA) evaluation I, II, III will be included in the sample group.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cukurova University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Cansel Bozer
specialist nurse
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Cansel Bozer
Role: PRINCIPAL_INVESTIGATOR
Cukurova University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Adana City Training and Research Hospital
Adana, Yüreğir / Adana, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CU-SBF-CB-02
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.